BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mels GC, Bellati G, Leandro G, Brunetto MR, Vicari O, Borzio M, Piantino P, Fornaciari G, Scudeller G, Angeli G. Fluctuations in viremia, aminotransferases and IgM antibody to hepatitis B core antigen in chronic hepatitis B patients with disease exacerbations. Liver. 1994;14:175-181. [PMID: 7968277 DOI: 10.1111/j.1600-0676.1994.tb00071.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Zavaglia C, Mondazzi L, Maggi G, Iamoni G, Gelosa F, Bellati G, Colloredo G, Bottelli R, Ideo G. Are alanine aminotransferase, hepatitis B virus DNA or IgM antibody to hepatitis B core antigen serum levels predictors of histological grading in chronic hepatitis B? Liver. 1997;17:83-87. [PMID: 9138277 DOI: 10.1111/j.1600-0676.1997.tb00785.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 0.7] [Reference Citation Analysis]
2 Kondili LA, Brunetto MR, Maina AM, Argentini C, Chionne P, La Sorsa V, Resuli B, Mele A, Rapicetta M. Clinical and molecular characterization of chronic hepatitis B in Albania: a country that is still highly endemic for HBV infection. J Med Virol. 2005;75:20-26. [PMID: 15543588 DOI: 10.1002/jmv.20231] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
3 Chu C, Liaw Y. Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion. J Viral Hepat 2007;14:147-52. [DOI: 10.1111/j.1365-2893.2006.00810.x] [Cited by in Crossref: 111] [Cited by in F6Publishing: 107] [Article Influence: 7.9] [Reference Citation Analysis]
4 Manesis EK, Papatheodoridis GV, Sevastianos V, Cholongitas E, Papaioannou C, Hadziyannis SJ. Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection. Am J Gastroenterol. 2003;98:2261-2267. [PMID: 14572577 DOI: 10.1111/j.1572-0241.2003.07715.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 43] [Article Influence: 1.8] [Reference Citation Analysis]
5 Puri P. Acute exacerbation of chronic hepatitis B: the dilemma of differentiation from acute viral hepatitis B. J Clin Exp Hepatol 2013;3:301-12. [PMID: 25755518 DOI: 10.1016/j.jceh.2013.08.014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
6 Raimondo G, Pollicino T, Squadrito G. Clinical virology of hepatitis B virus infection. Journal of Hepatology 2003;39:26-30. [DOI: 10.1016/s0168-8278(03)00135-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
7 Morisco F, Del Vecchio Blanco G, Tuccillo C, Galli C, Cirino S, Caporaso N. Long-term observation of HCV-positive patients with normal ALT values: persistence of a clinically healthy state. Research in Virology 1998;149:277-82. [DOI: 10.1016/s0923-2516(99)89006-2] [Cited by in Crossref: 8] [Article Influence: 0.3] [Reference Citation Analysis]
8 Charbel H, Lewis JH. Hepatitis B Reactivation in the Setting of Chemotherapy and Immunosuppression. In: Shetty K, Wu GY, editors. Chronic Viral Hepatitis. Totowa: Humana Press; 2010. pp. 307-36. [DOI: 10.1007/978-1-59745-565-7_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
9 Frei PC, Grob PJ. [Serologic diagnosis and follow-up of hepatitis B]. Soz Praventivmed 1998;43 Suppl 1:S10-3, S84-7. [PMID: 9833256 DOI: 10.1007/BF02042165] [Reference Citation Analysis]
10 Bonney JH, Osei-Kwasi M, Adiku TK, Barnor JS, Amesiya R, Kubio C, Ahadzie L, Olschläger S, Lelke M, Becker-Ziaja B, Pahlmann M, Günther S. Hospital-based surveillance for viral hemorrhagic fevers and hepatitides in Ghana. PLoS Negl Trop Dis 2013;7:e2435. [PMID: 24069490 DOI: 10.1371/journal.pntd.0002435] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
11 Yuen MF, Sablon E, Hui CK, Li TM, Yuan HJ, Wong DK, Doutreloigne J, Bogaerts V, Wong BC, Fan ST, Lai CL. Prognostic factors in severe exacerbation of chronic hepatitis B. Clin Infect Dis. 2003;36:979-984. [PMID: 12684909 DOI: 10.1086/374226] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 2.0] [Reference Citation Analysis]
12 Zavaglia C, Severini R, Tinelli C, Franzone JS, Airoldi A, Tempini S, Bettale G, Ideo G. A randomized, controlled study of thymosin-alpha1 therapy in patients with anti-HBe, HBV-DNA-positive chronic hepatitis B. Dig Dis Sci 2000;45:690-6. [PMID: 10759236 DOI: 10.1023/a:1005431323945] [Cited by in Crossref: 24] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
13 Falade-Nwulia O, Seaberg EC, Rinaldo CR, Badri S, Witt M, Thio CL. Comparative risk of liver-related mortality from chronic hepatitis B versus chronic hepatitis C virus infection. Clin Infect Dis 2012;55:507-13. [PMID: 22523269 DOI: 10.1093/cid/cis432] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
14 Vaillant A. Transaminase Elevations during Treatment of Chronic Hepatitis B Infection: Safety Considerations and Role in Achieving Functional Cure. Viruses 2021;13:745. [PMID: 33922828 DOI: 10.3390/v13050745] [Reference Citation Analysis]
15 Dou HY, Wu JC, Peng WL, Chang C, Chi WK, Chu YD, Hu CP. Analysis of T cell receptor Vbeta gene usage during the course of disease in patients with chronic hepatitis B. J Biomed Sci 1998;5:428-34. [PMID: 9845846 DOI: 10.1007/BF02255931] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
16 Flichman D, Colombatto P, Randone A, Baldi M, Bellati G, Negro F, Oliveri F, Colucci G, Verme G, Bonino F, Brunetto M. Quantitative detection of hepatitis C virus RNA in the serum of patients with chronic hepatitis C treated with interferon: A pilot study. Clinical and Diagnostic Virology 1997;8:63-70. [DOI: 10.1016/s0928-0197(97)00013-5] [Cited by in Crossref: 7] [Article Influence: 0.3] [Reference Citation Analysis]
17 Zignego AL, Fontana R, Puliti S, Barbagli S, Monti M, Careccia G, Giannelli F, Giannini C, Buzzelli G, Brunetto MR, Bonino F, Gentilini P. Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis. J Med Virol 1997;51:313-8. [DOI: 10.1002/(sici)1096-9071(199704)51:4<313::aid-jmv9>3.0.co;2-8] [Cited by in Crossref: 57] [Article Influence: 2.4] [Reference Citation Analysis]
18 Tsai WL, Sun WC, Cheng JS. Chronic Hepatitis B with Spontaneous Severe Acute Exacerbation. Int J Mol Sci. 2015;16:28126-28145. [PMID: 26703566 DOI: 10.3390/ijms161226087] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
19 Perrillo RP. Acute flares in chronic hepatitis B: The natural and unnatural history of an immunologically mediated liver disease. Gastroenterology. 2001;120:1009-1022. [PMID: 11231956 DOI: 10.1053/gast.2001.22461] [Cited by in Crossref: 279] [Cited by in F6Publishing: 264] [Article Influence: 14.0] [Reference Citation Analysis]
20 Mitsumoto F, Murata M, Ura K, Takayama K, Hiramine S, Shimizu M, Toyoda K, Ogawa E, Furusyo N, Hayashi J. The kinetics of the hepatitis B surface antigen level after the initiation of antiretroviral therapy for hepatitis B virus and human immunodeficiency virus coinfected patients. J Infect Chemother 2015;21:264-71. [PMID: 25596071 DOI: 10.1016/j.jiac.2014.12.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
21 Flink HJ, Sprengers D, Hansen BE, van Zonneveld M, de Man RA, Schalm SW, Janssen HL; HBV 99-01 Study Group. Flares in chronic hepatitis B patients induced by the host or the virus? Gut. 2005;54:1604-1609. [PMID: 15923670 DOI: 10.1136/gut.2004.062208] [Cited by in Crossref: 78] [Cited by in F6Publishing: 71] [Article Influence: 4.9] [Reference Citation Analysis]
22 Brahmania M, Lombardero M, Hansen BE, Terrault NA, Lok AS, Perrillo RP, Belle SH, Di Bisceglie AM, Feld JJ, Lee WM, Fried MW, Janssen HLA; Hepatitis B Research Network. Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection. Clin Gastroenterol Hepatol 2019;17:2541-2551.e2. [PMID: 30743006 DOI: 10.1016/j.cgh.2019.02.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
23 Hadziyannis E, Manesis E, Vassilopoulos D, Georgiou A, Archimandritis A. Performance characteristics of microparticle enzyme and chemiluminescence immunoassays for measurement of anti-HBc immunoglobulin M in sera of patients with HBeAg-negative chronic hepatitis B virus infection. Clin Vaccine Immunol 2008;15:385-7. [PMID: 18077614 DOI: 10.1128/CVI.00414-07] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
24 Jardi R, Buti M, Rodriguez-frias F, Cortina M, Esteban R, Guardia J, Pascual C. The value of quantiative detection of HBV-DNA amplified by PCR in the study of hepatitis B infection. Journal of Hepatology 1996;24:680-5. [DOI: 10.1016/s0168-8278(96)80263-7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
25 Brunetto MR, Oliveri F, Coco B, Leandro G, Colombatto P, Gorin JM, Bonino F. Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study. J Hepatol. 2002;36:263-270. [PMID: 11830339 DOI: 10.1016/s0168-8278(01)00266-5] [Cited by in Crossref: 231] [Cited by in F6Publishing: 63] [Article Influence: 12.2] [Reference Citation Analysis]
26 Fafi-Kremer S, Zarski JP. [What tests should be prescribed in HBs-positive patients]. Gastroenterol Clin Biol 2005;29:364-8. [PMID: 15864196 DOI: 10.1016/s0399-8320(05)80782-1] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
27 Mcgovern B. What Drives Hepatitis B Virus-Related Hepatic Flares? Virus, T Cells--Or a Bit of Both? Clinical Infectious Diseases 2004;39:133-5. [DOI: 10.1086/421409] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
28 Bekku D, Arai M, Imazeki F, Yonemitsu Y, Kanda T, Fujiwara K, Fukai K, Sato K, Itoga S, Nomura F, Yokosuka O. Long-term follow-up of patients with hepatitis B e antigen negative chronic hepatitis B: Follow-up of HBV carriers with anti-HBe. Journal of Gastroenterology and Hepatology 2011;26:122-8. [DOI: 10.1111/j.1440-1746.2010.06322.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
29 Honkoop P, de Man RA, Niesters HG, Zondervan PE, Schalm SW. Acute exacerbation of chronic hepatitis B virus infection after withdrawal of lamivudine therapy. Hepatology. 2000;32:635-639. [PMID: 10960461 DOI: 10.1053/jhep.2000.16333] [Cited by in Crossref: 165] [Cited by in F6Publishing: 146] [Article Influence: 7.9] [Reference Citation Analysis]
30 Petersen J, Dandri M, Bürkle A, Zhang L, Rogler CE. Increase in the frequency of hepadnavirus DNA integrations by oxidative DNA damage and inhibition of DNA repair. J Virol 1997;71:5455-63. [DOI: 10.1128/jvi.71.7.5455-5463.1997] [Cited by in Crossref: 38] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
31 Park JW, Kwak KM, Kim SE, Jang MK, Kim DJ, Lee MS, Kim HS, Park CK. Differentiation of acute and chronic hepatitis B in IgM anti-HBc positive patients. World J Gastroenterol 2015; 21(13): 3953-3959 [PMID: 25852281 DOI: 10.3748/wjg.v21.i13.3953] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
32 Kannangai R, Vivekanandan P, Netski D, Mehta S, Kirk GD, Thomas DL, Torbenson M. Liver enzyme flares and occult hepatitis B in persons with chronic hepatitis C infection. J Clin Virol. 2007;39:101-105. [PMID: 17452002 DOI: 10.1016/j.jcv.2007.03.006] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
33 Bonino F, Brunetto MR. Chronic hepatitis B e antigen (HBeAg) negative, anti-HBe positive hepatitis B: an overview. J Hepatol 2003;39 Suppl 1:S160-3. [PMID: 14708696 DOI: 10.1016/s0168-8278(03)00319-2] [Cited by in Crossref: 47] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
34 Colloredo G, Bellati G, Leandro G, Colombatto P, Rho A, Bissoli F, Brunetto MR, Angeli G, Ideo G, Bonino F. Quantitative analysis of IgM anti-HBc in chronic hepatitis B patients using a new "gray-zone" for the evaluation of "borderline" values. J Hepatol 1996;25:644-8. [PMID: 8938540 DOI: 10.1016/s0168-8278(96)80233-9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
35 Negro F, Giostra E, Rubbia-brandt L, Mentha G, Colucci G, Morel P, Quadri R, Perrin L, Hadengue A. IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation. J Med Virol 1998;56:224-9. [DOI: 10.1002/(sici)1096-9071(199811)56:3<224::aid-jmv8>3.0.co;2-9] [Cited by in Crossref: 14] [Article Influence: 0.6] [Reference Citation Analysis]
36 Chen JJ, Lin CY, Sheu MJ, Kuo HT, Sun CS, Tang LY, Wang SL, Tsai SL. Poor response to 18-month lamivudine monotherapy in chronic hepatitis B patients with IgM anti-HBc and acute exacerbation. Aliment Pharmacol Ther 2006;23:85-90. [PMID: 16393284 DOI: 10.1111/j.1365-2036.2006.02718.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
37 Zignego AL, Fontana R, Puliti S, Barbagli S, Monti M, Careccia G, Giannelli F, Giannini C, Buzzelli G, Brunetto MR. Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis. J Med Virol. 1997;51:313-318. [PMID: 9093946 DOI: 10.1002/(SICI)1096-9071(199704)51:4%3C313::AID-JMV9%3E3.0.CO;2-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Feld JJ, Ayers M, El-ashry D, Mazzulli T, Tellier R, Heathcote EJ. Hepatitis B virus DNA prediction rules for hepatitis B e antigen–negative chronic hepatitis B. Hepatology 2007;46:1057-70. [DOI: 10.1002/hep.21811] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 4.3] [Reference Citation Analysis]
39 Marcellin P, Mommeja-Marin H, Sacks SL, Lau GK, Sereni D, Bronowicki JP, Conway B, Trepo C, Blum MR, Yoo BC, Mondou E, Sorbel J, Snow A, Rousseau F, Lee HS. A phase II dose-escalating trial of clevudine in patients with chronic hepatitis B. Hepatology 2004;40:140-8. [PMID: 15239097 DOI: 10.1002/hep.20257] [Cited by in Crossref: 106] [Cited by in F6Publishing: 84] [Article Influence: 6.2] [Reference Citation Analysis]
40 Oketani M, Oketani K, Xiaohong C, Arima T. Low level wild-type and pre-core mutant hepatitis B viruses and hbeAg negative reactivation of chronic hepatitis B. J Med Virol 1999;58:332-7. [DOI: 10.1002/(sici)1096-9071(199908)58:4<332::aid-jmv3>3.0.co;2-q] [Cited by in Crossref: 10] [Article Influence: 0.5] [Reference Citation Analysis]
41 Burton AR, Maini MK. Human antiviral B cell responses: Emerging lessons from hepatitis B and COVID-19. Immunol Rev 2021;299:108-17. [PMID: 33559128 DOI: 10.1111/imr.12953] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]